-
One of the final barriers to availability of emergency contraception (EC) has been toppled with the Food and Drug Administration (FDA) approval of nonprescription sales of the EC drug, Plan B. The drug is manufactured by Barr Pharmaceuticals of Pomona, NY, and marketed by its Duramed subsidiary.
-
Your next patient is a 17-year-old female who is seeking contraception for pregnancy prevention. She is not sure if she wants to take the Pill, and says she's leery of wearing a contraceptive patch. What options can you offer her?
-
How much do you know about natural methods of family planning? While such options may be exactly what some women are seeking, many providers don't learn about them during their medical training.
-
Review the following scenario: a patient has used oral contraceptives for 15 years, starting her first pill pack at age 28. Now at age 43, she tells you, "I had three children by 28 when I started using the Pill. I got divorced three years ago, and now I'm remarried. Why can't I get pregnant? It must be the Pill." What is your counseling strategy?
-
While strides have been made in stemming gonorrhea, clinicians are advised to keep the sexually transmitted disease (STD) on the radar screen. Preliminary new data from the Centers for Disease Control and Prevention (CDC) show sharp increases in reported gonorrhea cases since 2000 in seven states: Alaska, California, Hawaii, Nevada, Oregon, Utah, and Washington.
-
-
-
We are all aware of the negative effects of unnecessary antibiotics. Antibiotic resistance is a current crisis in healthcare.
-
At the University of Pittsburgh Medical Center, laboratory-based surveillance of coagulase-negative staphylococci found that 4% were linezolid resistant.
-
In this report, Sauer and colleagues from the University of Pennsylvania describe the prevalence, significance, and management strategy for patients who have AV node reentrant tachycardia (AVNRT) in association with atrial fibrillation (AF).
